FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Allen Anthony Joseph 2. Issuer Name and Ticker or Trading Symbol Lucira Health, Inc. [ LHDX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Operations Officer
(Last)         (First)         (Middle)
C/O LUCIRA HEALTH, INC., 1412 62ND STREET
3. Date of Earliest Transaction (MM/DD/YYYY)
9/30/2021
(Street)
EMERYVILLE, CA 94608
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  9/30/2021    A    197240 (1) A $0.00  197240  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Represents grant of Restricted Stock Units (the "RSUs") payable solely in common stock of the Issuer that vest over a four-year period commencing on September 20, 2021 ("vesting start date"), with 25% of the shares subject to the RSUs vesting on the first anniversary of the vesting start date and the remainder of the shares subject to the RSUs vesting in 12 equal quarterly installments thereafter.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Allen Anthony Joseph
C/O LUCIRA HEALTH, INC.
1412 62ND STREET
EMERYVILLE, CA 94608


Chief Operations Officer

Signatures
/s/ Daniel George, Attorney-in-Fact for Anthony Joseph Allen 10/1/2021
**Signature of Reporting Person Date
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Lucira Health Charts.
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Lucira Health Charts.